Literature DB >> 15574779

Functional analysis of the contribution of RhoA and RhoC GTPases to invasive breast carcinoma.

Kaylene J Simpson1, Aisling S Dugan, Arthur M Mercurio.   

Abstract

Although the RhoA and RhoC proteins comprise an important subset of the Rho GTPase family that have been implicated in invasive breast carcinomas, attributing specific functions to these individual members has been difficult. We have used a stable retroviral RNA interference approach to generate invasive breast carcinoma cells (SUM-159 cells) that lack either RhoA or RhoC expression. Analysis of these cells enabled us to deduce that RhoA impedes and RhoC stimulates invasion. Unexpectedly, this analysis also revealed a compensatory relationship between RhoA and RhoC at the level of both their expression and activation, and a reciprocal relationship between RhoA and Rac1 activation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15574779     DOI: 10.1158/0008-5472.CAN-04-2247

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  73 in total

1.  Statins stimulate in vitro membrane FasL expression and lymphocyte apoptosis through RhoA/ROCK pathway in murine melanoma cells.

Authors:  Guillaume Sarrabayrouse; Cindy Synaeve; Kevin Leveque; Gilles Favre; Anne-Françoise Tilkin-Mariamé
Journal:  Neoplasia       Date:  2007-12       Impact factor: 5.715

Review 2.  Rho GTPases: functions and association with cancer.

Authors:  Saskia I J Ellenbroek; John G Collard
Journal:  Clin Exp Metastasis       Date:  2007-11-14       Impact factor: 5.150

3.  FOXO3a promotes tumor cell invasion through the induction of matrix metalloproteinases.

Authors:  Peter Storz; Heike Döppler; John A Copland; Kaylene J Simpson; Alex Toker
Journal:  Mol Cell Biol       Date:  2009-06-29       Impact factor: 4.272

4.  Loss of cell-cell contacts induces NF-kappaB via RhoA-mediated activation of protein kinase D1.

Authors:  Catherine F Cowell; Irene K Yan; Tim Eiseler; Amanda C Leightner; Heike Döppler; Peter Storz
Journal:  J Cell Biochem       Date:  2009-03-01       Impact factor: 4.429

Review 5.  Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.

Authors:  Behzad Yeganeh; Emilia Wiechec; Sudharsana R Ande; Pawan Sharma; Adel Rezaei Moghadam; Martin Post; Darren H Freed; Mohammad Hashemi; Shahla Shojaei; Amir A Zeki; Saeid Ghavami
Journal:  Pharmacol Ther       Date:  2014-02-26       Impact factor: 12.310

6.  Diverse roles for the paxillin family of proteins in cancer.

Authors:  Nicholas O Deakin; Jeanine Pignatelli; Christopher E Turner
Journal:  Genes Cancer       Date:  2012-05

7.  High-resolution imaging of the dynamic tumor cell vascular interface in transparent zebrafish.

Authors:  Konstantin Stoletov; Valerie Montel; Robin D Lester; Steven L Gonias; Richard Klemke
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-22       Impact factor: 11.205

8.  Myosin-interacting guanine exchange factor (MyoGEF) regulates the invasion activity of MDA-MB-231 breast cancer cells through activation of RhoA and RhoC.

Authors:  D Wu; M Asiedu; Q Wei
Journal:  Oncogene       Date:  2009-06-04       Impact factor: 9.867

9.  Protein kinase D1 regulates matrix metalloproteinase expression and inhibits breast cancer cell invasion.

Authors:  Tim Eiseler; Heike Döppler; Irene K Yan; Steve Goodison; Peter Storz
Journal:  Breast Cancer Res       Date:  2009-02-25       Impact factor: 6.466

Review 10.  Rac and Rho driving tumor invasion: who's at the wheel?

Authors:  Marc Symons; Jeffrey E Segall
Journal:  Genome Biol       Date:  2009-03-06       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.